Raleigh Capital Management »

iShares Dow Jones US Pharm Indx shares owned by Raleigh Capital Management

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Raleigh Capital Management from 13F filings

Historical chart of Raleigh Capital Management investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Raleigh Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Raleigh Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $65 1 65.00
2024-09-30 $80 1 80.00
2024-06-30 $1.7M 26k 66.32

More positions owned by Raleigh Capital Management

Ssga Active Tr Spdr Ssga Fxd (FISR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ssga Active Tr Spdr Ssga Us Sct (XLSR)
Microsoft Corporation (MSFT)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr Bloomberg High Y (JNK)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Spdr Gold Tr Gold Shs (GLD)
Exxon Mobil Corporation (XOM)

View all positions for Raleigh Capital Management

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Rockport Wealth
Bank of America Corporation
Brown Advisory Holdings Incorporated
LPL Financial
Royal Bank of Canada
Goldman Sachs Group
Wells Fargo & Company
Pallas Capital Advisors
Susquehanna International
Raymond James & Associates
Peapack Gladstone Financial Corp
Commonwealth Equity Services
UBS Group
Thrivent Financial for Lutherans

View all funds holding iShares Dow Jones US Pharm Indx